Solural Pharma ApS
http://soluralpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Solural Pharma ApS
Bukwang Speeds Lead Asset As It Eyes Danish Operation's Listing
Helped by a hefty financing earlier this year, Bukwang subsidiary Contera Pharma is poised to speed ongoing multinational Phase II trials with its lead asset for Parkinson’s-associated dyskinesia by hiring CNS experts as new top executives, as the Korean firm looks to take it public in ground-breaking move.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice